Analyst Upgrades

• TCF Financial (TCB) to buy from hold at Deutsche Bank.
• Exelon (EXC) to market perform from underperform at Wells Fargo.
• Nvidia (NVDA) and Boyd Gaming (BYD) upgraded to overweight from equal weight at Barclays.
• Estee Lauder (EL) to buy from neutral at UBS.
• Webster Financial (WBS) to buy from hold at Jefferies.
• Skilled Healthcare (SKH) to outperform from market perform at Morgan Keegan.
• Acorda Therapeutics (ACOR) to outperform from market perform at Leerink.
• NCR Corp. (NCR) to outperform from neutral at Wedbush.
• Barnes & Noble (BKS) to neutral from underperform and Pioneer Natural (PXD) to outperform from neutral at Credit Suisse.
• Autodesk (ADSK) to buy from neutral at Goldman.

Analyst Upgrades

• Piper Jaffray upgraded Edwards Lifesciences (EW) to overweight from neutral and raised its target price for shares to $77 from $53 after The New England Journal of Medicine reported the company's PARTNER Trial met primary endpoints.
• UBS upgraded Endo Pharmaceuticals (ENDP) to buy from neutral and raised its price target to $36 from $25. UBS is positive on Endo's creative strategic deals and believes the switch to Opana TRF from Opana ER will be easy. Additionally, the analyst believes pipeline expectations are very low.
• BMO Capital upgraded Nvidia (NVDA) to outperform from market perform based on expectations that share loss in the core GPU business will stop, Tegra momentum and valuation. The firm raised its price target to $16 from $9.
• FirstEnergy (FE) and Allegheny Energy (AYE) were upgraded to outperform from neutral at Credit Suisse.
• Mylan (MYL) was upgraded to conviction buy from buy at Goldman. Warner
• Chilcott (WCRX) was upgraded to overweight from equal weight at Morgan Stanley.

Analyst Upgrades

• Soleil upgraded Hologic (HOLX) to buy from hold on expectations the company's next-generation breast tomosynthesis instrument is likely to receive FDA approval. The firm raised its target price for shares to $20 from $16.
• ING Group upgraded Total (TOT) to buy from hold.
• BofA/Merrill raised Medicis (MRX) to neutral from underperform.
• CPFL Energia (CPL) was upgraded to buy from hold at Deutsche Bank.

Analyst Upgrades

• SunTrust upgraded Lennox (LII) to buy from neutral, given signs of improved residential HVAC equipment and service demand and a bottom in commercial lines. The firm has a $55 price target on the stock.
• Cowen upgraded Universal Display (PANL) to outperform from neutral. The firm expects OLED display growth to accelerate driven by increased handset and other mobile device penetration, followed by high-end TV and lighting applications.
• Canaccord upgraded Amylin (AMLN) to hold from sell following Roche's (RHHBY) delay in its Phase 3 study for taspo, a competitor to Amylin's bydureon. The firm has an $18 target on Amylin shares.
• DiamondRock Hospitality (DRH) was upgraded to buy from hold at Citigroup.
• Public Service (PEG) was upgraded to conviction buy from buy at Goldman.
• QuinStreet (QNST) was upgraded to overweight on valuation at Thomas Weisel.

Analyst Upgrades

• Weeden upgraded Nabors Industries (NBR) to buy from hold on expectations that U.S. land drillers will likely benefit from a more restrictive deepwater Gulf of Mexico drilling environment.
• Macquarie upgraded Cinemark (CNK) to outperform from neutral and has a $20 price target on the stock. The firm cites valuation, market share stabilization and Latin American pricing power.
• RBC Capital upgraded Edison International (EIX) to outperform from sector perform with a $43 target. The firm cited valuation and its belief that the company's unregulated businesses are well-positioned to accelerate as reasons for the upgrade.
• Canadian Pacific (CP) was upgraded to buy from hold at Stifel Nicolaus.
• FirstEnergy (FE) was upgraded to buy from hold at Citigroup.
• Joy Global (JOYG) was upgraded to buy from neutral at Longbow.

Analyst Upgrades

• Kaufman Bros. upgraded Vancelnfo (VIT) to buy from hold, citing better earnings visibility. The firm raised its target price for shares to $26 from $22.
• Janney Montgomery upgraded Progressive (PGR) to buy from neutral with an $18.50 price target, citing valuation and market share gains.
• JPMorgan upgraded Marriott (MAR) to overweight from neutral. The firm has a $36 price target on the stock.
• eBay (EBAY) was upgraded to outperform from neutral at Credit Suisse.
• Werner Enterprises (WERN) was upgraded to neutral from underperform at Credit Suisse.
• CNOOC (CEO) was upgraded to neutral from underperform at Macquarie.

Analyst Upgrades

• Deutsche Bank upgraded PNC Financial (PNC) to buy from hold on valuation as it believes the recent pullback in shares provides a buying opportunity. The firm raised its target on shares to $57 from $45.
• Kaufman Bros. upgraded Expedia (EXPE) to buy from hold on valuation as it finds the risk/reward on shares attractive following the company's Q4 results and believes revenue margin concerns are overblown. The firm has a $27 price target on the stock.
• Jesup & Lamont upgraded Chipotle Mexican Grill (CMG) to hold from sell following the company's Q4 results to reflect its improving traffic trends. The firm raised its target on shares to $96 from $81. Shares were also upgraded at BofA/Merrill to buy from neutral.
• Rio Tinto (RTP) was upgraded to outperform from neutral at Credit Suisse.
• FirstEnergy (FE) was upgraded to hold from underperform at Jefferies.
• Marriott (MAR) was upgraded to perform from underperform at Oppenheimer.

U.S. stock futures were higher Thursday morning, after EU President said they are ready to help Greece out of its debt crisis. Investors also await a jobs report to get a better indication of the health of the labor market.

On Wednesday, U.S. stocks closed with small losses as Wall Street digested a testimony from Federal Reserve Chairman Ben Bernanke that hinted at a gradual tightening of monetary policy that offset any optimism out of hopes of a Greece rescue in Europe.

Analyst Upgrades

• Goldman upgraded Potash (POT) to conviction buy from buy and said a "near-worst-case" scenario on 2010 potash pricing is reflected in potash valuations and that they continue to expect a fundamental potash demand recovery in 2010. Note that the firm also upgraded Mosaic (MOS) to buy from neutral. Potash's price target is $138.
• Morgan Stanley upgraded Alcoa (AA) to overweight from equal weight based on expectations for alumina to continue to rally in 2H10. The firm has a $22 target on the stock.
• Baird upgraded Seagate (STX) to outperform from neutral and raised its target to $25 from $22 based on expectations that IT hardware spend will continue to accelerate through 2010, HDD supply conditions will continue to be constrained at least into the March quarter, and that enterprise strength and favorable supply conditions will drive shares higher in 2010.
• Intel (INTC) was upgraded to overweight from equal weight at Barclays.
• Resource Capital (RSO) was raised to outperform from market perform at FBR Capital.
• Palm (PALM) was upgraded to hold from sell at Morgan Joseph.

Analyst upgrades:

• Deutsche Bank upgraded T. Rowe Price (TROW) to buy from hold due to valuation and solid core trends. The firm raised its target on shares to $57 from $55. Note the firm downgraded Franklin Resources to hold from buy (see below).
• KeyBanc upgraded U.S. Steel (X) to buy from hold based on stable domestic cost environment in 2010 and likelihood of sustained higher spot pricing. The firm has a $65 target on shares.
• Goldman upgraded Canadian Natural Resources (CNQ) to buy from neutral, citing oil leverage, sizable resource base and free cash flow. The firm raised its target to $90 from $88.
• Darden (DRI) was upgraded to buy from neutral at UBS.
• Carnival (CCL) was upgraded to overweight from neutral at JPMorgan.
• AmerisourceBergen (ABC) was upgraded to overweight from equal weight at Barclays.

Analyst Upgrades

• Citigroup upgraded Reynolds American (RAI) to buy from hold to reflect its improved outlook for the company's market share and pricing. Citi also sees a greater chance of British American Tobacco (BTI) bidding for the rest of Reynolds American it doesn't already own. The firm raised its target price on Reynolds to $59 from $52.
• Stephens upgraded Simmons First National (SFNC) to overweight from equal weight to reflect the company's balance sheet and potential for accretive FDIC-assisted acquisitions. The firm raised its target on shares to $32 from $29.
• FBR Capital upgraded Astoria Financial (AF) to market perform from underperform on expectations the company's net charge-offs will peak in the fourth quarter, limiting downside risk. The firm raised its target on shares to $11 from $10.
• First Solar (FSLR) was upgraded to buy from hold at Collins Stewart.
• Brown-Forman (BF.B) was upgraded to neutral from underweight at JPMorgan.
• Juniper (JNPR) was upgraded to conviction buy from buy at Goldman.

Analyst initiations:

• Allegheny (NYSE: AYE) was initiated with a buy at Citigroup as attractive at current levels. Target is $33.
• PPL Corp. (NYSE: PPL) was initiated with a buy at Citigroup. Citi believes PPL's earnings power from the Pennsylvania regulated utility market is being underappreciated. Target is $35.
• FirstEnergy (NYSE: FE) was initiated with a Buy at Citigroup who believes the company's current valuation doesn't reflect its transition to full market-based rates in 2011. Target is $56.
• Waste Management (NYSE: WM) coverage resumed with a Neutral at Goldman.
• Exxon (NYSE: XOM) initiated with a Buy at Soleil. Target is $90.
• Vodafone (NYSE: VOD) was initiated with a Buy at ING Group.

Analyst upgrades:

• Jefferies upgraded MDS Inc. (NYSE: MDZ) to Buy from Hold on valuation as it believes shares are pricing in a "worst case" scenario at current levels. The firm keeps a $6.50 target on the stock.
  
• JP Morgan upgraded Continental (NYSE: CAL) to Overweight from Neutral on valuation as it believes the recent sell-off is overdone. The firm keeps a $13 price target on the stock.
• Thomas Weisel is positive on Allergan's (NYSE: AGN) diverse product portfolio, global infrastructure, vertical integration, and deep pipeline. The firm upgraded shares to Overweight from Market Weight and has a $54 target on the stock.
• NetLogic (NASDAQ: NETL) was upgraded to Buy from Neutral at Piper.
  
• Dover (NYSE: DOV) was raised to Buy from Neutral at Banc of America/Merrill.
  
• Map Pharmaceuticals (NASDAQ: MAPP) was upgraded at Argus to Hold from Sell.

Analyst upgrades:

• Baird upgraded URS Corp. (NYSE: URS) to Outperform from Neutral and raised its target to Outperform from Neutral based on momentum of new wins from stimulus funds and expectations for additional nuclear contracts.
• Jefferies upgraded EnerSys (NYSE: ENS) to Buy from Hold following the recent share weakness as it believes volumes have stopped declining and the June quarter is likely the bottom. The firm raised its target price to $18 from $11.
• RBC Capital upgraded Camden Property (NYSE: CPT) to Outperform from Sector Perform citing the company's improved financial capacity and portfolio position. The firm raised its target price to $34 from $23.
• CBS Corp (NYSE: CBS) was upgraded to Equal Weight from Underweight at Barclays.
• UDR (NYSE: UDR) was raised to Sector Perform from Underperform at RBC Capital and to Outperform from Market Perform at Keefe Bruyette.
• Zale (NYSE: ZLC) was upgraded to Buy from Neutral at BofA/Merril.

MOST NOTEWORTHY: Lockheed Martin Corp (LMT) and Nokia Corp (NOK) were today's most notable upgrades:

• Freidman Billings upgraded shares of Lockheed Martin Corp (NYSE: LMT) to Outperform from Market Perform, with a $110 target, citing a strong Q4 report and improving outlook.

• Nokia Corp (NYSE: NOK) was upgraded to Buy from Hold at Deutsche Bank, as they believe the company's positive drivers have accrued faster than expected, including a product refresh and a compelling valuation.

OTHER UPGRADES:

• Friedman Billings upgraded shares of Imclone Systems Inc (NASDAQ: IMCL) to Market Perform from Underperform based on valuation and catalysts expected over the next 12 months.

• Lehman Brothers upgraded shares of FirstEnergy Corp (NYSE: FE) to Overweight from Equal-Weight. They feel the regulatory overhang has been removed with the recent reasonable outcome on rates in Pennsylvania and an improved outlook in Ohio.

• UBS upgraded STMicroelectronics NV (NYSE: STM) to Buy from Reduce as they expect growth from higher sales, a separation in its flash-memory unit, and a decline in inventories at Nokia (NOK), a client. Additionally, the firm raised its global phone handset unit estimate.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).